Table 1.
Epileptic mechanisms in Alzheimer’s disease.
Gene | Mutation/Variants | Models | Postulated Mechanisms | Channel Function | Phenotypes | References |
---|---|---|---|---|---|---|
GABRG2 | Q390X | cells | Impaired oligomerization, ER retention | reduced | GEFS+, DS | [30] |
GABRG2 | R82Q | cells | Impaired oligomerization, ER Retention | reduced | FS, CAE | [117] |
GABRG2 | Q390X, W429X, W461X | cells | Impaired oligomerization, ER Retention | reduced | FS, GEFS+, DS | [77] |
GABRG2 | Q390X | mice | ER rentention, dominant negative suppression | reduced | [62] | |
GABRG2 | Q390X | Mice | protein accumulation, aggregation | reduced | GEFS+, DS | [118] |
GABRG2 | Q390X | mice | increased neuroinflamamtion | reduced | DS | [79] |
GABRG2 | IVS6+2T->G | cell mice | NMD, ERAD | reduced | CAE, FS | [119] |
GABRG2 | A106T, I107T, P282S, etc. | cell | ERAD, ER retention | reduced | DEE | [120] |
GABRG2 | S443delC | cells | ERAD, ER retention? | reduced | GEFS+ | [121] |
GABRB3 | N328D | cells | ERAD, ER retention | reduced | LGS | [74] |
GABRB3 | E357K | cells | ERAD, ER retention | reduced | JAE | [74] |
GABRA1 | A322D | cells | ERAD, ER retention | reduced | JME | [122] |
SLC6A1 | G234S | cells | ERAD, ER retention | reduced | DS | [51] |
SLC6A1 | P361T | cells | ERAD, ER retention | reduced | autism, CAE | [52] |
SLC6A1 | V125M | cells | ERAD, ER Retention | reduced | CAE, ADHD | [123] |
SLC6A1 | 22 mutations | cells | ER Retention, dominant negative effect? | reduced | various phenotypes | [53] |
Abbreviations: CAE = childhood absence epilepsy; FS = febrile seizures; GEFS+ = generalized epilepsy with febrile seizures plus; DEE = developmental epileptic encephalopathy; LGS = Lennox-Gastaut syndrome, DS = Dravet syndrome; JAE = juvenile absence epilepsy; ADHD = attention deficit hyperactivity disorder.